Month: February 2023

2024.07.17
Summary of the most important events and achievements of the Genomtec S.A.

2024.06.25
Webinar: Trends in the M&A Market Specific to In-Vitro Diagnostics | 27 June, 2024, 3:00 p.m. (CEST)

2024.04.22
Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

2024.03.26
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

Archive

2023.02.28

Genomtec S.A. intensifies M&A process

The management board of Genomtec S.A., a medical technology company, plans to raise additional funds to support maximization of the ...
Read
2023.02.16

Genomtec S.A. debuted on the Main Market of the Warsaw Stock Exchange

On 16th February 2023, Genomtec S.A. debuted on the Main Market of the Warsaw Stock Exchange Video from the debut: ...
Read
2023.02.09

Genomtec’s first listing on the Main Market of the Warsaw Stock Exchange

16 February 2023 – the date for Genomtec’s first listing on the Main Market of the Warsaw Stock Exchange. We have great pleasure to invite all ...
Read

Archive